Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Evaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid Tumors

Phase I

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer Prostate Cancer Risk Clinic (PCRC) Study

Prostate

Descriptive Study of Pain Syndrome in Survivors of Head and Neck Cancer

Head/Neck

A Phase I/Ib Study Evaluating Single-Agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers

Multiple Cancer Types

Prospective Observational Trial of a Biodegradable Hyaluronic Acid Spacer in Prostate Cancer Radiotherapy

Prostate

Developing a Trustworthy Multilevel Intervention to Improve Equity in Lung Cancer Screening

Lung

APOLLO-B - A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)

CTQJ230A - A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease (CVD)

SOS-AMI - Protocol ID-07-076A301 Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

APOLLO-B Expanded Access Protocol ALN-TTR02-014 Expanded Access Protocol to Provide Patisiran to Patients with Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) with Cardiomyopathy